Pandya A P, Barkakaty B N, Narasimham M V
Regional Office for Health & Family Welfare, Industrial Estate Corner, Anand Estate Bapunagar, Ahmedabad.
J Commun Dis. 1994 Jun;26(2):61-7.
The present study describes the comparative efficacy of chloroquine and amodiaquine in two different presumptive therapy areas of north eastern India. The study recorded insignificant differences in respect of Mean Parasite Clearance Time (MPCT) of sensitive cases, MPCT and Mean Parasite Recrudescence Time (MPRT) of RI resistant cases and recrudescence rate in chloroquine and amodiaquine therapy areas. It is concluded that amodiaquine is not a superior drug as compared to chloroquine. In the chloroquine resistance area, Plasmodium falciparum developed cross resistance to amodiaquine and this phenomenon appears to be unidirectional. However, amodiaquine may help to slow-down the rate of precipitation of higher grade of resistance.
本研究描述了氯喹和氨酚喹在印度东北部两个不同的推定治疗地区的比较疗效。该研究记录了敏感病例的平均寄生虫清除时间(MPCT)、对氯喹耐药病例的MPCT和平均寄生虫复发时间(MPRT)以及氯喹和氨酚喹治疗地区的复发率方面的无显著差异。得出的结论是,与氯喹相比,氨酚喹并非更优的药物。在氯喹耐药地区,恶性疟原虫对氨酚喹产生了交叉耐药性,且这种现象似乎是单向的。然而,氨酚喹可能有助于减缓更高等级耐药性的出现速度。